Records containing: Recurrent Childhood Visual Pathway Glioma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-03-20Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
-
CLINICAL_TRIALS study record update · 2022-04-25A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
-
CLINICAL_TRIALS study record update · 2021-11-30A Phase II Randomized Trial of Lenalidomide (NSC # 703813) in Pediatric Patients With Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
-
CLINICAL_TRIALS study record update · 2018-07-16A Children's Oncology Group Protocol for Collecting and Banking Pediatric Brain Tumor Research Specimens
-
CLINICAL_TRIALS study record update · 2017-04-28Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-2018F-FDOPA PET/CT or PET/MRI in Patients With Gliomas
-
CLINICAL_TRIALS study record update · 2016-03-07A Phase I Clinical Trial of AZD2171 in Children With Recurrent or Progressive Central Nervous System (CNS) Tumors
-
CLINICAL_TRIALS study record update · 2014-11-05A PHASE 1/2 STUDY OF RO4929097, AN ORAL SMALL MOLECULE INHIBITOR OF GAMMA-SECRETASE, IN CHILDREN WITH RELAPSED/REFRACTORY SOLID OR CNS TUMORS, LYMPHOMA, OR T-CELL LEUKEMIA
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-07-02A Phase I Study of Vorinostat and Bortezomib in Children With Refractory or Recurrent Solid Tumors, Including CNS Tumors and Lymphomas
-
CLINICAL_TRIALS study record update · 2013-07-02A PHASE I STUDY OF FLAVOPIRIDOL (NSC# 649890; IND# 46211) IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC SOLID TUMORS OR LYMPHOMAS
-
CLINICAL_TRIALS study record update · 2013-06-14Phase II Trial of Irinotecan in Children With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2013-06-05A Phase I Study of Oxaliplatin (NSC# 266046, IND #57004) and Irinotecan in Pediatric Patients With Refractory Solid Tumors and Lymphomas